PERSPECTA

News from every angle

← Back to headlines

Lilly's Jaypirca Shows Extended Progression-Free Survival in CLL Treatment

New data for Lilly's drug Jaypirca indicates extended progression-free survival in patients with Chronic Lymphocytic Leukemia, marking a potential advancement in treatment.

13 Apr, 12:13 — 13 Apr, 12:13
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed133d ago

Lilly Jaypirca data shows extended progression-free survival in CLL

Read full article →

Related Stories

Octopuses Engage in Territorial Conflicts, Striking Fish

16h ago

Gallery Showcases Bizarre Deep-Sea Creatures Resembling Aliens

16h ago

Partial Lunar Eclipse Peaks Friday Morning, Visible Across Europe and North America

17h ago

Magnitude 5 Earthquake and Aftershocks Strike Costa Rica

18h ago